
CAS 1945950-21-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS :Formule :C23H26N6O4S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :514.6203Ref: IN-DA01ENKB
1mg186,00€5mg246,00€10mg545,00€25mg639,00€50mgÀ demander100mgÀ demander200mgÀ demanderPARG Inhibitor PDD00017273
CAS :Formule :C23H26N6O4S2Degré de pureté :≥ 98.0%Couleur et forme :White to yellow or beige powderMasse moléculaire :514.62PDD00017273
CAS :<p>PDD00017273 is a radiosensitizing PARG) inhibitor with antitumor or activity for the study of epithelial ovaries.</p>Formule :C23H26N6O4S2Degré de pureté :99.14% - 99.21%Couleur et forme :SolidMasse moléculaire :514.621-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS :Degré de pureté :95%Masse moléculaire :514.6199951PDD 00017273
CAS :Produit contrôléFormule :C23H26N6O4S2Couleur et forme :NeatMasse moléculaire :514.62PDD 00017273
CAS :<p>PDD 00017273 is a monoclonal antibody that targets the adenosine diphosphate-ribose (ADP-ribose) termini of cancer cells. It binds to the ADP-ribose termini and prevents them from being labeled with monomers, which are necessary for DNA synthesis. PDD 00017273 has been shown to specifically bind to human cancers, including breast, prostate, lung, colorectal, leukemia, and lymphoma. The drug has been shown to produce tumor shrinkage in animal models and is currently in clinical trials for treatment of human cancers. 1) 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding</p>Formule :C23H26N6O4S2Degré de pureté :Min. 95%Masse moléculaire :514.62 g/mol






